#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	3868	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2441	471.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1629	1629	C	511	C	441	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6342	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3877	490.9	0	.	n	.	0	T695C	SNP	695	695	T	1179	1179	C	494	C	421	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6342	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3877	490.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1821	1821	A	564	A,G	495,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6342	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3877	490.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2455	2455	C	579	C,A,T	512,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6342	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3877	490.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2529	2529	A	599	A,C	501,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6342	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3877	490.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3081	3081	C	592	C,A	500,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	662	folP	855	855	100.0	folP.l15.c17.ctg.1	1901	104.2	1	SNP	p	R229S	0	.	.	685	687	CGC	1209	1211	CGC	149;149;149	C;G;C	127;126;122	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1312	gyrA	2751	2751	99.89	gyrA.l6.c17.ctg.1	3778	104.3	1	SNP	p	S91F	0	.	.	271	273	TCC	750	752	TCC	129;129;129	T;C;C	105;107;107	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1312	gyrA	2751	2751	99.89	gyrA.l6.c17.ctg.1	3778	104.3	1	SNP	p	D95N	0	.	.	283	285	GAC	762	764	GAC	126;126;127	G;A;C	104;107;106	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1312	gyrA	2751	2751	99.89	gyrA.l6.c17.ctg.1	3778	104.3	1	SNP	p	D95G	0	.	.	283	285	GAC	762	764	GAC	126;126;127	G;A;C	104;107;106	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	536	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1567	102.5	1	SNP	p	G45D	1	.	.	133	135	GAC	572	574	GAC	157;156;157	G;A;C	135;138;139	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	382	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1265	90.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1282	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3343	115.2	0	.	p	.	0	A443V	NONSYN	1327	1329	GCC	1864	1866	GTC	151;151;153	G,T;T;C	130,1;131;130	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1282	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3343	115.2	1	SNP	p	D86N	0	.	.	256	258	GAC	793	795	GAC	163;164;165	G;A;C	141;141;143	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1282	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3343	115.2	1	SNP	p	S88P	0	.	.	262	264	TCC	799	801	TCC	165;165;165	T;C,A;C	141;139,1;141	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1118	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3080	108.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1764	1766	GGC	141;141;141	G;G;C	125;126;123	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	1078	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2748	117.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1441	1443	GCA	164;160;159	G;C;A	137;134;138	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1078	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2748	117.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1444	1446	ATC	159;159;158	A;T;C	137;136;137	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1078	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2748	117.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1456	1458	GTG	157;157;156	G,T;T;G	134,1;135;132	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1078	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2748	117.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1456	1458	GTG	157;157;156	G,T;T;G	134,1;135;132	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1078	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2748	117.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1960	1962	ACC	127;128;128	A;C;C	113;112;114	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1078	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2748	117.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2014	2016	GCG	125;125;124	G;C,G;G	112;109,1;101	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1078	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2748	117.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2014	2016	GCG	125;125;124	G;C,G;G	112;109,1;101	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1078	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2748	117.6	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2137	2139	GGC	133;133;131	G;G;C,T	112;114;112,1	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1078	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2748	117.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2146	2148	GGC	132;133;132	G;G;C	110;110;111	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1078	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2748	117.6	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2164	2166	CTG	135;135;136	C;T;G	112;109;112	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	1264	ponA	2397	2397	99.92	ponA.l15.c4.ctg.1	3410	111.2	1	SNP	p	L421P	1	L421P	NONSYN	1261	1263	CTG	1773	1775	CCG	126;126;126	C;C;G	107;104;104	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	696	porA	1146	1146	99.83	porA.l6.c17.ctg.1	2117	98.8	0	.	p	.	0	S22G	NONSYN	64	66	AGC	531	533	GGC	113;112;111	G;G;C	97;94;94	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	696	porA	1146	1146	99.83	porA.l6.c17.ctg.1	2117	98.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	713	713	C	114	C	98	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	102	porB1a	984	178	90.11	porB1a.l15.c4.ctg.1	1361	21.9	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1208	1210	AAT	9;9;9	A;A;T	9;9;9	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	102	porB1a	984	178	90.11	porB1a.l15.c4.ctg.1	1361	21.9	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1211	1213	AAT	9;9;8	A;A;T	9;9;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	102	porB1a	984	178	90.11	porB1a.l15.c4.ctg.1	1361	21.9	0	.	p	.	0	A222V	NONSYN	664	666	GCT	1223	1225	GTT	8;8;8	G;T;T	7;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	102	porB1a	984	178	90.11	porB1a.l15.c4.ctg.1	1361	21.9	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1235	1237	GCA	8;8;8	G;C;A	7;7;7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	102	porB1a	984	178	90.11	porB1a.l15.c4.ctg.1	1361	21.9	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1258	1260	GTA	6;6;6	G;T;A	5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	102	porB1a	984	178	90.11	porB1a.l15.c4.ctg.1	1361	21.9	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1267	1267	A	7	A	5	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	708	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	2026	104.0	0	.	p	.	0	T18M	NONSYN	52	54	ACG	551	553	ATG	171;171;170	A;T;G	140;141;144	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	708	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	2026	104.0	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	926	928	CAA	125;125;126	C;A;A	111;111;112	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	708	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	2026	104.0	0	.	p	.	0	E212D	NONSYN	634	636	GAA	1133	1135	GAT	115;113;113	G;A;T	102;100;102	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	708	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	2026	104.0	0	.	p	.	0	H213G	NONSYN	637	639	CAT	1136	1138	GGT	113;112;112	G,T;G;T	102,1;101;102	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	708	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	2026	104.0	0	.	p	.	0	V215A	NONSYN	643	645	GTT	1142	1144	GCT	112;111;111	G;C;T	102;100;100	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	708	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	2026	104.0	0	.	p	.	0	S220T	NONSYN	658	660	AGC	1157	1159	ACT	114;113;113	A,G;C;T	102,1;102;100	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	708	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	2026	104.0	0	.	p	.	0	R257M	NONSYN	769	771	AGG	1268	1270	ATG	131;131;131	A;T;G	113;113;111	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	708	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	2026	104.0	0	.	p	.	0	R258S	NONSYN	772	774	AGG	1271	1273	AGC	129;128;128	A,G;G;C	113,1;112;112	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	708	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	2026	104.0	0	.	p	.	0	A259G	NONSYN	775	777	GCT	1274	1276	GGT	128;127;127	G;G;T	112;110;113	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	708	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	2026	104.0	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1388	1390	AAC	145;146;146	A;A;C	123;122;123	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	708	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	2026	104.0	1	SNP	p	G120K	0	.	.	358	360	GGC	857	859	GGC	142;142;141	G;G;C	126;126;124	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2370	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5118	138.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	406	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	1244	97.5	1	SNP	p	V57M	1	.	.	169	171	ATG	630	632	ATG	154;155;158	A;T;G,T	136;136;134,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
